February 20, 2025 - 17:00

In a notable turn of events, futures for the S&P 500, Dow, and Nasdaq are experiencing a retreat as investors shift their focus to the upcoming outlook from Walmart. This development comes amid ongoing discussions surrounding economic policies and their potential impacts on consumer spending.
With the retail giant set to release its forecasts, market participants are keenly observing how the company plans to navigate the current economic landscape, particularly in light of rising inflation and changing consumer behaviors. Walmart's performance is often seen as a bellwether for the broader retail sector, making its insights particularly valuable to analysts and investors alike.
As uncertainties loom over the market, including the implications of recent governmental cost-cutting measures and tariffs, stakeholders are bracing for potential volatility. The interplay between corporate earnings reports and macroeconomic policies will likely dictate market movements in the coming days, as investors weigh their options in an unpredictable environment.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...